(19)
(11) EP 4 572 842 A1

(12)

(43) Date of publication:
25.06.2025 Bulletin 2025/26

(21) Application number: 23853762.5

(22) Date of filing: 18.08.2023
(51) International Patent Classification (IPC): 
A61N 1/36(2006.01)
A61B 5/388(2021.01)
A61B 5/00(2006.01)
A61N 1/05(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 5/388; A61N 1/36139; A61B 5/4041; A61N 1/3615; A61N 1/36062; A61B 5/4836
(86) International application number:
PCT/AU2023/050786
(87) International publication number:
WO 2024/036380 (22.02.2024 Gazette 2024/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 19.08.2022 AU 2022902371

(71) Applicant: Saluda Medical Pty Ltd
Macquarie Park, New South Wales 2113 (AU)

(72) Inventors:
  • KARANTONIS, Dean Michael
    Macquarie Park, New South Wales 2113 (AU)
  • SINGLE, Peter Scott Vallack
    Macquarie Park, New South Wales 2113 (AU)
  • GMEL, Gerrit Eduard
    Macquarie Park, New South Wales 2113 (AU)
  • PARKER, Daniel John
    Macquarie Park, New South Wales 2113 (AU)
  • GILERT, Samuel Nicholas
    Macquarie Park, New South Wales 2113 (AU)

(74) Representative: Abel & Imray LLP 
Westpoint Building James Street West
Bath BA1 2DA
Bath BA1 2DA (GB)

   


(54) IMPROVED FEEDBACK CONTROL OF NEURAL STIMULATION THERAPY